• Mashup Score: 5

    Scientists at Fox Chase Cancer Center have identified a mutation in a common oncogene — a gene that can cause cancer — that may play an important role in colon cancer. Researchers also showed how this mutation could be targeted therapeutically.

    Tweet Tweets with this article
    • A recent study by Fox Chase researchers identifies a gene mutation that may serve as a promising target for highly personalized treatments in colorectal cancer. Read more from Jonathan Chernoff, MD, PhD, Cancer Center Director & senior author on the study: https://t.co/Qozv4XJ4di

  • Mashup Score: 0

    At Fox Chase Cancer Center, every advancement begins with a single focus: the patient. On Friday, June 13, 2025, Fox Chase officially opened the new Oncology Satellite Pharmacy—a facility built to dramatically increase the speed and safety with which life-saving medications reach patients.

    Tweet Tweets with this article
    • Fox Chase just celebrated the ribbon cutting of its new Oncology Satellite Pharmacy! This important addition will help ensure patients have easier, faster access to the medications they need, all while improving safety, care coordination, and convenience: https://t.co/koKacWa7xy https://t.co/Oy3QVH1yRA

  • Mashup Score: 8

    The process of DNA amplification, the increase in the number of copies of a gene, has long been known to play a role in cancer and other diseases. More recently, research has focused on regulating this process for therapeutic benefit. Now, scientists at Fox Chase Cancer Center have “connected the dots” with a new paper that reviews decades of research and DNA amplification discoveries.

    Tweet Tweets with this article
    • How did DNA amplification shape cancer research? Scientists at Fox Chase Cancer Center explore its evolution and impact in a new review paper. Read more from corresponding author on the review, Johnathan Whetstine, PhD, @CeiFccc @WhetstineLab: https://t.co/cIfOhk5cuh

  • Mashup Score: 12

    Marital status significantly impacts survival rates for patients with colorectal cancer, according to a new study co-authored by a Fox Chase Cancer Center researcher that was presented today at the American Society of Clinical Oncology’s (ASCO) Annual Meeting. Married individuals were found to have better survival rates than single or separated and divorced or widowed individuals.

    Tweet Tweets with this article
    • A new study from Fox Chase Cancer Center explores how marital status may influence outcomes for patients with colorectal cancer. Discover what researchers found and why social factors matter in cancer care: https://t.co/kaquk4teki #ColorectalCancer @NVijayvergiaMD

  • Mashup Score: 1

    Screening for prostate cancer often involves a prostate-specific antigen (PSA) test, which measures the level of PSA (a protein made by the prostate) in the blood. When your PSA level is elevated, it could be a sign of prostate cancer.

    Tweet Tweets with this article
    • Screening for prostate cancer often involves a prostate-specific antigen test, which measures the level of PSA in the blood. When your PSA level is elevated, it could be a sign of prostate cancer. On the blog, Dr. Andreas Correa shares what you should know https://t.co/6mDH5zKGq7 https://t.co/WnyuHjBQKB